financetom
Business
financetom
/
Business
/
Power Metals Higher As Seals $5 Million Pre-payment Cesium Oxide Deal With Albermarle
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Power Metals Higher As Seals $5 Million Pre-payment Cesium Oxide Deal With Albermarle
Mar 10, 2026 10:23 PM

10:57 AM EST, 12/12/2025 (MT Newswires) -- Power Metals ( PWRMF ) up 7.5% on last look, said Friday it has sealed a $5 million pre-payment deal for cesium oxide concentrate with NYSE-listed Albermarle. The pre-payment commitment is conditional on Power Metals ( PWRMF ) securing necessary approvals and permits to commence mining at Case Lake, Ontario.

The company will receive $2 million following execution of the pre-payment commitment. The remainder $3 million will be received when Power Metals ( PWRMF ) delivers its Environmental Compliance Approval for the project in 2026.

Winsome Resources is also assigning its Case Lake offtake rights to Albemarle, but will retain its 15.8% equity stake in Power Metals ( PWRMF ), a statement said.

"This agreement is a significant step for Power Metals ( PWRMF ) and a strong outcome for our shareholders. The pre-payment structure provides access to funding without dilution, allowing us to advance Case Lake while preserving the value of the Company. With the Project's extremely low capital requirements, under C$8 million required, this support positions us well to move toward production and unlock the full potential of our cesium opportunity," said board chair Johnathan More.

Power Metal shares are up $0.065, to $0.925 on the TSX Venture Exchange.

Price: 0.92, Change: +0.06, Percent Change: +6.98

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
PTC Therapeutics Loses EU Authorization for Translarna in Duchenne Muscular Dystrophy
PTC Therapeutics Loses EU Authorization for Translarna in Duchenne Muscular Dystrophy
Mar 28, 2025
09:52 AM EDT, 03/28/2025 (MT Newswires) -- PTC Therapeutics ( PTCT ) said Friday that the European Commission has adopted the recommendation of the Committee for Medicinal Products for Human Use to not renew Translarna's marketing authorization for nonsense mutation Duchenne muscular dystrophy. The commission indicated that under EU Directive 2001/83, individual member states in the European Union can still...
Why Is Milestone Pharmaceuticals Stock Plunging Today?
Why Is Milestone Pharmaceuticals Stock Plunging Today?
Mar 28, 2025
Milestone Pharmaceuticals Inc. ( MIST ) announced on Friday that its New Drug Application for CARDAMYST (etripamil) nasal spray, aimed at treating acute episodes of paroxysmal supraventricular tachycardia, received a Complete Response Letter from the U.S. Food and Drug Administration (FDA). The company’s shares are trading lower following the news. While the FDA did not raise concerns about the clinical...
BTG Pactual's Andre Esteves expected to join Eneva's board
BTG Pactual's Andre Esteves expected to join Eneva's board
Mar 28, 2025
SAO PAULO, March 28 (Reuters) - The chairman of Brazil's investment bank BTG Pactual, billionaire Andre Esteves, is expected to join the board of power generator Eneva , according to a proposal released on Friday for Eneva's shareholders' meeting. Under the proposal, Eneva's board of directors, composed of seven members, would see two new members as two others exit. Rodrigo...
Knightscope Launches $1.7 Million Registered Direct Offering
Knightscope Launches $1.7 Million Registered Direct Offering
Mar 28, 2025
09:52 AM EDT, 03/28/2025 (MT Newswires) -- Knightscope ( KSCP ) said Friday it has launched a registered direct offering of 625,000 common shares at $2.75 apiece to raise about $1.7 million in gross proceeds. The offering will likely be completed around March 31, the company said. Knightscope ( KSCP ) also said it plans to allocate the net proceeds...
Copyright 2023-2026 - www.financetom.com All Rights Reserved